Previous close | 27.09 |
Open | 27.11 |
Bid | 26.96 x 0 |
Ask | 26.96 x 0 |
Day's range | 26.90 - 27.48 |
52-week range | 19.64 - 27.82 |
Volume | |
Avg. volume | 471,840 |
Market cap | 4.998B |
Beta (5Y monthly) | 1.01 |
PE ratio (TTM) | 14.59 |
EPS (TTM) | 1.86 |
Earnings date | 24 Jul 2024 |
Forward dividend & yield | 1.34 (4.95%) |
Ex-dividend date | 30 Sept 2024 |
1y target est | 31.50 |
Velvet CARE has decided to invest in a third Valmet Advantage DCT tissue line for its mill in Osada Klucze, Poland. The order includes an extensive automation package, a control valve package, and Industrial Internet solutions. The target is to meet consumers' increasing demand for high-quality tissue products with low environmental impact.
According to Valmet Oyj's Annual General Meeting's decision, Valmet's Nomination Board consists of the representatives of Valmet's four largest shareholders as of July 1, and the Chair of the Board of Directors as an expert member. Should a shareholder not wish to exercise his/her nomination right, the right shall be transferred to the next largest shareholder who otherwise would not be entitled to nominate a member.
Valmet has received two orders from one of its major customers in Asia-Pacific. One order includes a complete papermaking line from stock preparation to reel and winders, a comprehensive automation solution package as well as spare parts and consumables packages. The other order includes a paper machine rebuild with automation and services. Both will produce uncoated woodfree grades, and the start-ups are scheduled for 2026.